|
|
 |
|
Viewing report
|
|
|
|
The World Orthopaedic Market Report 2008
Espicom Business Intelligence Ltd, Dec 2007, Pages: 216
The world’s ageing population and growing economic muscle in the emerging economies are just two of the trends which are driving significant growth in the orthopaedics sector. But what does the future hold and which technologies and companies will thrive? This new and original 225 page report will tell you.
THIS REPORT ANSWERS KEY QUESTIONS
- What annual growth is expected for the spinal sector to 2011 and what will the US$ value be?
- Who are the 8 leading companies in the spinal sector and what % share of the market do they have?
- What are the prospects for Zimmer, DePuy and Stryker in their battle to lead the orthopaedics sector?
- In which geographic region is the orthopaedic market expected to grow with a CAGR of 13%?
- What are the main technology and demographic growth drivers which will sustain positive growth in orthopaedics over the next 5 years?
- What influence is private equity having on the corporate landscape?
Key Areas Addressed:
- Forecasts to 2011 for the major orthopaedic sector markets
- Market share data by company and product sector
- Evaluation of orthopaedic markets by geographical region
- Social, market and product growth drivers
- A review of recent key events
- A comprehensive review of 30 leading companies
A complete assessment of markets, products and players can be found in...The World Orthopaedic Market Report 2008.
Few areas of the medical device industry have such a positive outlook
The global orthopaedic market is estimated to have been worth approximately US$29.1 billion in 2006, following growth of 8.8% over the previous year. According to our data, the spinal market became the largest segment during 2006, surpassing the knee implant market for the first time.
The fastest growing segments are orthobiologics, spinal and trauma, whilst the more established markets for reconstruction implants and arthroscopy equipment are exhibiting more modest growth rates.
Growth is being fuelled by a number of factors, including the ageing population, the uptake of orthopaedic surgery at an earlier age, physiological problems due to the increasing incidence of obesity, the development of better and longer-lasting implants and materials, as well as new procedures, in particular, minimally-invasive procedures.
Spinal markets continue to forge ahead
The spinal implant market experienced approximately 10% growth, excluding currency effects, and was worth around US$5.3 billion in 2006. This segment is one of the fastest-growing markets in orthopaedics, fuelled by the ageing population, treatments for younger patients, the development of better implants, materials and procedures, higher patient demand and the move from fusion technologies to motion-preserving devices. Having grown by 17% in 2005, however, the market slowed in 2006. While there is strong demand for spinal technology, the market environment is difficult, with the clinical requirements of both the FDA for product approval and payers for reimbursement leading to the need to invest much time and money in order for products to be accepted.
Orthobiologics: increasingly important
The global market for orthobiologics was estimated at US$2.3 billion in 2006. This market is projected to almost double by 2010 and reach US$5.3 billion by 2011 at a CAGR of 18.3 per cent. Used increasingly in spinal, total joint, trauma and soft tissue surgeries, synthetic bone graft substitutes and resorbables are beginning to replace traditional autografts and allografts (bone bank grafts) which account for more than 75% of today's bone graft procedures.
Bone graft substitutes, processed allograft products, and genetically engineered bone growth factors have significant future potential within orthopaedics. As the global population continues to age and the average level of physical activity grows, the number of orthopaedic procedures which require the use of bone grafts and substitutes will continue to increase. For example, in the spinal market, degenerative disc disease afflicts nearly half the US population between 40 and 60 years of age and approximately 90% of Americans over 60.
All orthopaedic sectors covered
- Joint replacement
- Trauma
- Spine
- Orthobiologics
Customers who bought this item also bought
The Orthopaedic Company Review
Orthopaedic Market Report 2009
European Markets for Orthopaedic Surgical Instruments
The European Market for Orthopaedic Bracing and Support
The Top 40 Manufacturers Of Orthopaedic Implants In Europe
European Orthopaedic Biomaterials Markets
Advances in Medical Device Technology for Orthopaedic Applications (Technical Insights)
Orthopaedic Bone Cements
Eastern European Orthopaedic Implants Markets
Orthopaedic Implants Markets in Europe
aap Implantate AG Company Profile
Key M&A Events in the Spinal Surgery Market in 2008
|
|
|
|
